Evidence map›Paper›PMID 30611425›Full record

ArticleMethods in enzymology2019

Synthesis and NMR Characterization of the Prenylated Peptide, a-Factor.

Taysir K Bader, Todd M Rappe, Gianlugi Veglia, Mark D Distefano

Open access · greenAbstract read
In one paragraph

Article in Methods in enzymology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Taysir K BaderUniversity of Minnesota, Twin Cities, Minneapolis, MN, United States.
Todd M RappeUniversity of Minnesota, Twin Cities, Minneapolis, MN, United States.
Gianlugi VegliaUniversity of Minnesota, Twin Cities, Minneapolis, MN, United States.
Mark D DistefanoUniversity of Minnesota, Twin Cities, Minneapolis, MN, United States. Electronic address: diste001@umn.edu.
Twin Cities Orthopedics · USUniversity of Minnesota · US

Funding

Enzymatic Protein LabelingR01GM084152 · NIGMS · UNIVERSITY OF MINNESOTA · PI DISTEFANO, MARK D · 2010 to 2019
$2.6M
Dysregulation of Protein Prenylation in the Pathogenesis of Alzheimer's DiseaseRF1AG056976 · NIA · UNIVERSITY OF MINNESOTA · PI DISTEFANO, MARK D, LI, LING · 2017 to 2017
$1.9M
Structure, Function and Conformational Dynamics of the Ste14p MethyltransferaseR01GM106082 · NIGMS · PURDUE UNIVERSITY · PI HRYCYNA, CHRISTINE A · 2013 to 2017
$1.4M
NIA NIH HHS RF1 AG056976NIGMS NIH HHS R01 GM084152NIGMS NIH HHS R01 GM106082
6 · The paper itself

Abstract

Protein and peptide prenylation is an essential biological process involved in many signal transduction pathways. Hence, it plays a critical role in establishing many major human ailments, including Alzheimer's disease, amyotrophic lateral sclerosis (ALS), malaria, and Ras-related cancers. Yeast mating pheromone a-factor is a small dodecameric peptide that undergoes prenylation and subsequent processing in a manner identical to larger proteins. Due to its small size in addition to its well-characterized behavior in yeast, a-factor is an attractive model system to study the prenylation pathway. Traditionally, chemical synthesis and characterization of a-factor have been challenging, which has limited its use in prenylation studies. In this chapter, a robust method for the synthesis of a-factor is presented along with a description of the characterization of the peptide using MALDI and NMR. Finally, complete assignments of resonances from the isoprenoid moiety and a-factor from COSY, TOCSY, HSQC, and long-range HMBC NMR spectra are presented. This methodology should be useful for the synthesis and characterization of other mature prenylated peptides and proteins.

Indexed as

Chromatography, AffinityFluorenesHumansMating FactorNuclear Magnetic Resonance, BiomolecularPeptidesProtein PrenylationSaccharomyces cerevisiaeSolid-Phase Synthesis TechniquesSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationTriphenylmethyl Compoundsalpha-factor (Saccharomyces cerevisiae)FluorenesMating FactorPeptidesTriphenylmethyl Compoundstrityl chloridea-FactorC-terminal esterFarnesylationLipidationNMRPeptidePheromonePrenylation

Identifiers

PMID30611425
PMCPMC8816421
OpenAlexW2906170270

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.